Baseline characteristics of ACS patients between pre-pandemic months matched to 1^st and 2^nd COVID waves. by Sana Sheikh (773675)

Subjects:

Clinical presentation, management, and hospital outcome of ACS patients admitted during 1^st and 2^nd COVID waves and matched pre-pandemic months. by Sana Sheikh (773675)

Subjects:

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited pupicidal activity against pupae of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

S1 Data - by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited adulticidal activity against adult of <i>A</i>. <i>albopictus</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

The response of the <i>A</i>. <i>albopictus</i> larval Glutathione S-transferase (GST) enzyme increased 7.8-fold in response to <i>M</i>. <i>robertsii</i>-derived copper nanopartic... by Perumal Vivekanandhan (4863484)

Subjects:

Schematic diagram of entomopathogen derived copper nanoparticles (CuNPs) and their toxic effects on target and non-target species. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited larvicidal activity against larvae of <i>A</i>. <i>albopictu</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>E</i>. <i>eugeniae</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Entomopathogenic fungi-derived copper nanoparticles (CuNPs) exhibited minimal toxicity effects against <i>A</i>. <i>salina</i> at 24 and 48h post treatment. by Perumal Vivekanandhan (4863484)

Subjects:

Overview of study procedures. by Matthew G. Vinson (22593374)

Subjects:

Intent to decrease use of OTC NSAIDs and NSAID exposure. by Matthew G. Vinson (22593374)

Subjects:

Moderating analysis for Opportunity and Motivation. (A) Moderating effect of Opportunity between group and intent to decrease OTC NSAIDs immediately post-intervention. by Matthew G. Vinson (22593374)

Subjects:

Demographic and clinical characteristics of the study cohort by group. by Matthew G. Vinson (22593374)

Subjects:

Results for the primary and secondary outcomes in regular over-the-counter NSAID users randomized to intervention and control groups at baseline and 4 weeks after the intervention,... by Matthew G. Vinson (22593374)

Subjects:

Longitudinal assessment of animal weights and tumor metrics. by Robert Botelho (20308297)

Subjects:

Spatial exploration patterns of non-tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

Subjects:

Study timeline and methodological overview. by Robert Botelho (20308297)

Subjects:

Spatial exploration patterns of tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

Subjects: